KingMed Diagnostics Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
9,529
- Stock Symbol
-
603882
- Investments
-
11
- Share Price
-
$4.09
- (As of Wednesday Closing)
KingMed Diagnostics General Information
Description
Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2024, KingMed has 50 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.
Contact Information
Website
www.kingmed.com.cnCorporate Office
- No. 10, Spiral Third Road
- 3rd Floor, International Bio Island
- Guangzhou, Guangdong 510000
- China
Corporate Office
- No. 10, Spiral Third Road
- 3rd Floor, International Bio Island
- Guangzhou, Guangdong 510000
- China
KingMed Diagnostics Stock Performance
As of 18-Nov-2026, KingMed Diagnostics’s stock price is $4.09. Its current market cap is $1.9B with 463M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.09 | $4.12 | $3.16 - $5.83 | $1.9B | 463M | 12M | $0.09 |
KingMed Diagnostics Financials Summary
As of 30-Sep-2026, KingMed Diagnostics has a trailing 12-month revenue of $855M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,822,171 | 1,658,998 | 1,603,247 | 3,944,564 |
| Revenue | 855,244 | 838,574 | 1,001,963 | 1,207,035 |
| EBITDA | 56,228 | 31,568 | 15,377 | 184,638 |
| Net Income | 40,611 | (24,091) | (53,131) | 90,939 |
| Total Assets | 1,390,466 | 1,372,723 | 1,423,528 | 1,660,084 |
| Total Debt | 127,303 | 119,434 | 102,518 | 81,710 |
KingMed Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
KingMed Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
KingMed Diagnostics Patents
KingMed Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250257401-A1 | Biomarker for tuberous sclerosis complex with no mutation identified in tsc1 or tsc2 gene, and uses thereof | Pending | 03-Nov-2022 | ||
| WO-2024092942-A1 | Biomarker for tuberous sclerosis complex-no mutation identified and use thereof | Inactive | 03-Nov-2022 | ||
| WO-2022266790-A1 | Method for reducing artificially introduced artefact mutations in high-flux sequencing, and application | Inactive | 21-Jun-2021 | ||
| US-20240221866-A1 | Method of reducing artefact variants in high throughput-sequencing and uses thereof | Pending | 21-Jun-2021 | ||
| US-12579828-B2 | Method and system for identifying target region of digital pathology slide, device, and medium | Active | 30-Nov-2020 | G06V20/695 |
KingMed Diagnostics Signals
KingMed Diagnostics Investments (11)
KingMed Diagnostics’s most recent deal was a IPO with Distinct HealthCare for . The deal was made on 06-Feb-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Distinct HealthCare | 06-Feb-2026 | IPO | Clinics/Outpatient Services | ||
| GeneMind | 27-May-2025 | PE Growth/Expansion | Diagnostic Equipment | ||
| GeneMind | 01-Aug-2023 | Later Stage VC | Diagnostic Equipment | ||
| Biotree (Laboratory Services) | 20-Dec-2022 | Later Stage VC | Laboratory Services (Healthcare) | ||
| Guhai Tianmu | 24-Jul-2021 | Corporate | Other Healthcare Technology Systems |
KingMed Diagnostics ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
26.33 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Services
Subindustry
of 97
Rank
Percentile
KingMed Diagnostics Exits (1)
KingMed Diagnostics’s most recent exit was on 07-Nov-2017 from AnchorDx. The exit was categorized as with 6 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| AnchorDx | 07-Nov-2017 | Completed |
|
KingMed Diagnostics FAQs
-
When was KingMed Diagnostics founded?
KingMed Diagnostics was founded in 2006.
-
Where is KingMed Diagnostics headquartered?
KingMed Diagnostics is headquartered in Guangzhou, China.
-
What is the size of KingMed Diagnostics?
KingMed Diagnostics has 9,529 total employees.
-
What industry is KingMed Diagnostics in?
KingMed Diagnostics’s primary industry is Laboratory Services (Healthcare).
-
Is KingMed Diagnostics a private or public company?
KingMed Diagnostics is a Public company.
-
What is KingMed Diagnostics’s stock symbol?
The ticker symbol for KingMed Diagnostics is 603882.
-
What is the current stock price of KingMed Diagnostics?
As of 18-Nov-2026 the stock price of KingMed Diagnostics is $4.09.
-
What is the current market cap of KingMed Diagnostics?
The current market capitalization of KingMed Diagnostics is $1.9B.
-
What is KingMed Diagnostics’s current revenue?
The trailing twelve month revenue for KingMed Diagnostics is $855M.
-
What is KingMed Diagnostics’s annual earnings per share (EPS)?
KingMed Diagnostics’s EPS for 12 months was $0.09.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process